Al Bahlani, SA, Al Rashdi, RM., Kumar S, Al Sanawi, SS, Al Bahri, MA, Shalaby, AA,2017. Calpain-1 Expression in Triple Negative Breast Cancer; A potential prognotic factor independent of the poliferative/apoptotic Index. Biomed Research International (2017);1-10 American Cancer Society (2015) „Global Cancer Facts & Figures 3rd Edition.‟,
American Cancer Society, (800), pp. 1–64. doi: 10.1002/ijc.27711.
Anda, P. et al. (2018) „Gambaran stadium dan jenis histopatologi kanker payudara di Subbagian Bedah Onkologi RSUP Sanglah Denpasar tahun 2015-2016‟, 9(1), pp. 80–84.
Balbita R, Kumar N, Karwasra RK, Singh M, Malik JS, Kaur A. 2014.
Reproduktive risk factors associated with breast carcinoma in a tertiary care hospital of north India; a case control study Indian journal of cancer. July - September 2014; 51 : 251-255
Banwell, C. M. et al. (2005) „Cancer Therapy : Preclinical Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue‟, 25(9), pp. 3579–
3587.
Bretherton-Watt, D. et al. (2001) „Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population.‟, British journal of cancer, 85(2), pp. 171–175.
Chen, W. Y. et al. (2005) „Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer Risk‟, Cancer Epidemiology Biomarkers
& Prevention, 14(10), pp. 2335–2339.
Chuang, E. et al. (2012) „Breast cancer subtypes in Asian-Americans differ according to Asian ethnic group‟, Journal of Immigrant and Minority Health, 14(5), pp. 754–758.
Clendenen, T. V. et al. (2015) „Genetic polymorphisms in vitamin D metabolism and signaling genes and risk of breast cancer: A nested case-control study‟, PLoS ONE, 10(10), pp. 1–11.
Colagar, A. H., Firouzjah, H. M. and Halalkhor, S. (2015) „Breast Cancer Vitamin D Receptor Poly ( A ) Microsatellite Polymorphism and 25-Hydroxyvitamin D Serum Levels : Association with Susceptibility to Breast Cancer‟, 18(2), pp. 119–125.
Cutolo, M. (2012) „The challenges of using vitamin D in cancer prevention and prognosis‟, Israel Medical Association Journal, 14(10), pp. 637–639.
Deeb, K. K., Trump, D. L. and Johnson, C. S. (2007) „Vitamin D signalling pathways in cancer: potential for anticancer therapeutics‟, Nat Rev Cancer, 7(9), pp. 684–700.
Doré, J. (2014) „A ccess L a vitamine D , vitamine ou hormone ?‟, 21(3).
Feldman, D. et al. (2014) „The role of vitamin D in reducing cancer risk and progression‟, Nature Reviews Cancer. Nature Publishing Group, 14(5), pp. 342–357.
Guy, M. et al. (2004) „Vitamin D receptor gene polymorphisms and breast cancer risk.‟, Clinical cancer research : an official journal of the American Association for Cancer Research, 10(16), pp. 5472–81.
Haddad, S. (2014) „Vitamin-D receptor ( VDR ) gene polymorphisms ( Taq-I &
Apa-I ) in Syrian healthy population‟, MGENE. Elsevier B.V., 2, pp.
646–650.
Hamajima, N. et al. (2012) „Menarche, menopause, and breast cancer risk:
Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies‟, The Lancet Oncology.
Elsevier Ltd, 13(11), pp. 1141–1151.
Harianto (2005) „Risiko Penggunaan Pada Reseptor Kb Di Perjan Rs‟, Majalah Ilmu Kefarmasian, II(1), pp. 84–99.
Hines, S. L. et al. (2010) „Breast cancer survivors and vitamin D: A review‟, Nutrition. Elsevier Ltd, 26(3), pp. 255–262.
Holick, M. F. and Chen, T. C. (2008) „Vitamin D defciency: a worldwide problem with health consequences‟, American Journal of Clinical Nutrition, 87(4), p. 1080S–6S.
InfoDatin, P. D. dan I. K. R. I. (2015) „Situasi penyakit kanker 4‟, Stop Kanker.
Ingles, S. a et al. (2000) „Vitamin D receptor genotype and breast cancer in Latinas (United States).‟, Cancer causes & control : CCC, 11(1), pp. 25–
30.
Jaime G, Abelardo M, Garcia, C. A. (2013) „Imflamatory breast cancer‟, Department of Medical Direction Instituto Nacional de Cancerología-Mexico, Mexico city, (3), pp. 4–8.
Joanne Current E, T. V. (1999) „Association Of A Vitamin D Receptor Polymorphism With Sporadic Breast Cancer Development‟,
726(February), pp. 723–726.
Kaaks, R. et al. (2005) „Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)‟, Journal of the National Cancer Institute, 97(10), pp. 755–765.
Kamiska, M.,Ciszewski, T., Miotta, P. 2015. Breast Cancer Risk factor.
Manupause review Prz Menopausalany 2015; 14(3); 196-202
Kang, P. et al. (2010) „Vitamin D Related Genes, CYP24A1 and Colon Cancer Rsik‟, Ratio, 36(3), pp. 490–499.
Kawase, T. et al. (2010) „Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan‟, Cancer Science, 101(5), pp. 1234–1240.
Khan, M. I. et al. (2014) „Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches (Review)‟, International Journal of Oncology, 44(2), pp. 349–363.
Köstner, K. et al. (2009) „The relevance of Vitamin D Receptor (VDR) gene polymorphisms for cancer: A review of the literature‟, Anticancer Research, 29(9), pp. 3511–3536.
Lawler, K. et al. (2017) „Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: A case control study‟, Breast Cancer Research. Breast Cancer Research, 19(1), pp. 1–15.
Lamiri FZ, Bouayad A, Hasswane N, Ahid S, Mrabeth M, Barkat; A risk factor for breast cancer of different age groups; Maroccan Data Open Journal of obstetric and gynecology, 2015; 5 ; 79-87
Leong, S. P. L. et al. (2010) „Is Breast Cancer the Same Disease in Asian and Western Countries?‟, World Journal of Surgery, 34(10), pp. 2308–2324.
Li WH, Gu Z, Wang H, Nekrutenko A (2001) Evolutionary analyses of teh human genome, Nature 409 : 847-849
Lue, J. K. (2015) „Vitamin D and Reduction of Breast Cancer Risk‟, (3), pp. 172–
180.
Makki, J. (2015) „Diversity of breast carcinoma: Histological subtypes and clinical relevance‟, Clinical Medicine Insights: Pathology, 8(1), pp. 23–
31.
relevance: Clinical Medicine Insights: Pathology 2015:8: 23-31
Mansi, J. L. et al. (2001) „Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population‟, British Journal of Cancer, 85(March), pp. 171–175.
Maruotti, N. and Cantatore, F. P. (2010) „Vitamin D and the immune system‟, Journal of Rheumatology, 37(3), pp. 491–495.
Mazzilli, S. A., Reid, M. E. and Foster, B. A. (2012) „Vitamin D and Cancer Chemoprevention‟, 3(April), pp. 175–189.
Mehta, R. G. et al. (2013) „Vitamin D and breast cancer: Emerging concepts‟, Cancer Letters. Elsevier Ireland Ltd, 334(1), pp. 95–100.
Mishra, D. K. et al. (2013) „Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women‟, 8(3).
Moukayed, M. and Grant, W. B. (2013) „Molecular link between vitamin D and cancer prevention‟, Nutrients, 5(10), pp. 3993–4021.
Nani, D. (2009) „Analisis Faktor-Faktor Yang Berhubungan Dengan Kejadian Kanker Payudara Di Rumah Sakit Pertamina Cilacap‟, Jurnal Keperawatan Soedirman, 4(2), pp. 61–66.
Narvaez, C. J. et al. (2014) „The impact of vitamin D in breast cancer: Genomics, pathways, metabolism‟, Frontiers in Physiology, 5 JUN(June), pp. 1–10.
Nath, A. et al. (2014) „Age , Stage , Parity and Region : Epidemiology of Breast cancer in Bihar‟, 13(2), pp. 7–10.
Nguyen, J. et al. (2014) „A Matched Case-Control Study of Risk Factors for
Pusparini (2014) „Defisiensi Vitamin D terhadap penyakit‟. Jakarta: Bagian Patologi Klinik Fakultas Kedokteran Universitas Trisakti Jakarta, pp.
90–95.
Reimers, L. L. et al. (2015) „Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk‟, Cancer Causes and Control,
26(2), pp. 187–203.
Reimers, L. L. et al. (2016) „Vitamin D Releted Gene Polymorphisms, Plasma 25-Hydroxyvitamin D, and Breast Cancer Risk‟, 26(2), pp. 187–203.
Roche, V. (2010) „Panduan Penangganan Kanker Payudara‟, Buklet Kanker payudara. Available at: Kanker payudara.
RSUP-HAM, M. R. team (2017) „Medical Record RSUP-HAM Medan‟.
Sadot Eran, Ser Yee Lee, Constantinos T Sofolenos, S. (2017) „hepatic resection or ablation for isolated breast cancer liver metastasis‟, HHS Public Access, 264(1), pp. 147–154.
Saez, S. et al. (1993) „William L. McGuire Memorial Symposium. 1,25(OH)2D3 modulation of mammary tumor cell growth in vitro and in vivo.‟, Breast cancer research and treatment, 27(1–2), pp. 69–81.
Shan, J. et al. (2012) „Genome-Wide Association Studies ( GWAS ) breast cancer susceptibility loci in Arabs : susceptibility and prognostic implications in Tunisians‟, pp. 715–724.
Slattery, M. L. (2007) „Vitamin D Receptor Gene (VDR) Associations with Cancer‟, Nutrition Reviews, 65(SUPPL.2).
Sonar Panigoro, Bethy S Hernowo, H. P. (2017) „Panduan Nasional Pelayanan Kedokteran Kanker Payudara di Indonesia‟, Kementerian kesehatan republik indonesia.
Surakasula A, Nagarjunapu GC, K.V and Raghavaiah. 2014. Camporative study of pre and post manopausal breast cancer; Risk factor, presentation, characteristics and management. Journal of Reseacrh in Pharmacy practice / Jan-Mar Vol.3;1 : 12-17
Stunkard, A. J. (2009) „NIH Public Access‟, Psychiatry: Interpersonal and Biological Processes, 162(3), pp. 214–220.
Tang, X. Y. et al. (2016) „Histopathological characteristics of breast ductal carcinoma in situ and association with imaging findings‟, Breast Cancer.
Springer Japan, 23(3), pp. 491–498.
Thakkar, A. et al. (2016) „Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer‟, Breast Cancer Research and Treatment.
Springer US, 157(1), pp. 77–90.
Thorne, J. and Campbell, M. J. (2008) „The vitamin D receptor in cancer.‟, The
Trabert B, Malone KE, Daling JR, et al (2007) Vitamin D reseptor polymorphisms and breast cancer risk in large population based case control study of Caucasian and African American women Breast Cancer Rs.9
Trieu, P. D. Y., Mello-Thoms, C. and Brennan, P. C. (2015) „Female breast cancer in Vietnam: a comparison across Asian specific regions.‟, Cancer biology & medicine, 12(3), pp. 238–45.
Tsiaras, W. G. and Weinstock, M. A. (2011) „Factors influencing vitamin d status‟, Acta Dermato-Venereologica, 91(2), pp. 115–124.
La Vecchia, C. et al. (2011) „Overweight, Obesity, Diabetes, and Risk of Breast Cancer: Interlocking Pieces of the Puzzle‟, The Oncologist, 16(6), pp.
726–729.
Wang, K. et al. (2016) „Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.‟, BMC cancer. BMC Cancer, 16(1), p. 674.
Watson, R. R. (2013) Hand Book of vitamin D in human health. First publ.
Netherland: Wageningen Academic publisher The Netherland.
Welsh, J. E. et al. (2003) „Vitamin D-3 receptor as a target for breast cancer prevention‟, Journal of Nutrition, 133(7), p. 2425S–2433S.
Yang, B. et al. (2014) „Current evidence on the four polymorphisms of VDR and breast cancer risk in Caucasian women‟, Meta Gene. The Authors, 2(1), pp. 41–49.
Zaki, M., Kamal, S. and Basha, W. A. (2017) „ScienceDirect Association of vitamin D receptor gene polymorphism ( VDR ) with vitamin D deficiency , metabolic and inflammatory markers in Egyptian obese women‟, Genes & Diseases. Elsevier Ltd, 4(3), pp. 176–182.
Zhang, K. and Song, L. (2014) „Association between vitamin D receptor gene polymorphisms and breast cancer risk: A meta-analysis of 39 studies‟, PLoS ONE, 9(4).